Back
Milestone Pharmaceuticals Vs. Xenon Pharmaceuticals Industry Stock Comparison
Sell
50
MIST
Milestone Pharmaceuticals
Last Price:
1.84
Seasonality Move:
-2.66%
Buy
54
XENE
Xenon Pharmaceuticals
Last Price:
40.43
Seasonality Move:
29.08%
Sell
50
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
- The current Milestone Pharmaceuticals [MIST] share price is $1.86. The Score for MIST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Xenon Pharmaceuticals (XENE)
is a Buy
Is Xenon Pharmaceuticals a Buy, Sell or Hold?
- The current Xenon Pharmaceuticals [XENE] share price is $39.34. The Score for XENE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- XENE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing slight buying pressure.
XENE Stock Price Chart
What is Xenon Pharmaceuticals's stock price today?
-
The Xenon Pharmaceuticals share price today is $39.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XENE is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 64.71 | Buy |
| Chaikin Money Flow: | 302912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.44 - 1.82) | Buy |
| Bollinger Bands (100): | (1.36 - 1.64) | Buy |
XENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 39.85 | Sell |
| Chaikin Money Flow: | 281378 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.38 - 44.16) | Sell |
| Bollinger Bands (100): | (38.88 - 42.9) | Sell |
MIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.8 | Buy |
| 20-day SMA: | 1.66 | Buy |
| 50-day SMA: | 1.57 | Buy |
| 200-day SMA: | 1.56 | Buy |
| 8-day EMA: | 1.78 | Buy |
| 20-day EMA: | 1.7 | Buy |
| 50-day EMA: | 1.6 | Buy |
| 200-day EMA: | 1.73 | Buy |
XENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.93 | Sell |
| 20-day SMA: | 42 | Sell |
| 50-day SMA: | 41.21 | Sell |
| 200-day SMA: | 41.56 | Sell |
| 8-day EMA: | 40.5 | Sell |
| 20-day EMA: | 41.49 | Sell |
| 50-day EMA: | 41.36 | Sell |
| 200-day EMA: | 40.75 | Sell |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.20 per share.
Xenon Pharmaceuticals Earnings Growth & XENE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.42 per share.
Milestone Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xenon Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||